Pharma.AI launches to apply artificial intelligence to drug discovery and development

IMAGE: Pharmaceutical Artificial Intelligence view more Credit: InSilico Medicine, Inc. March 15, 2016, Baltimore, MD – Insilico Medicine, one of the leaders in advanced signaling pathway activation analysis and deep learning for aging and cancer research is proud to announce the formation of the Pharmaceutical Artificial Intelligence division focused on applying latest advances in artificial intelligence to streamline drug discovery and drug repurposing processes and significantly cutting time to market. “Since its inception Insilico Medicine is taking the umbrella view on aging research developing biomarkers and drug candidates in a broad number of fields. We collaborate with some of the largest pharmaceutical companies, cosmetics companies and academic institutions on a number of disease- or drug-specific projects. However, our focus on aging and “we do everything” approach is confusing for many of…


Link to Full Article: Pharma.AI launches to apply artificial intelligence to drug discovery and development